[{"AccountsPayableCurrent_0_Q3_USD":1974000.0,"OperatingIncomeLoss_1_Q3_USD":-33361000.0,"OperatingIncomeLoss_3_Q3_USD":-90630000.0,"OriginationOfNotesReceivableFromRelatedParties_3_Q3_USD":null,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":8000.0,"OtherAssetsCurrent_0_Q3_USD":461000.0,"OtherAssetsNoncurrent_0_Q3_USD":1262000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q3_USD":12000.0,"OperatingExpenses_3_Q3_USD":110776000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_3_Q3_USD":-22000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":2040000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-9158000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-11074000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_1_Q3_USD":12000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3285000.0,"OtherLongTermInvestments_0_Q3_USD":14256000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-29000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":484000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-355000.0,"OperatingExpenses_1_Q3_USD":33627000.0,"NotesReceivableRelatedPartiesCurrent_0_Q3_USD":null,"Liabilities_0_Q3_USD":21349000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":484109000.0,"LiabilitiesCurrent_0_Q3_USD":15317000.0,"MinorityInterest_0_Q3_USD":9574000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":408139000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-32643000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-42737000.0,"NotesReceivableRelatedPartiesNoncurrent_0_Q3_USD":3784000.0,"NetIncomeLoss_1_Q3_USD":-31158000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-484000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-2040000.0,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1_Q3_USD":-31641000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_1_Q3_USD":0.0,"NonoperatingIncomeExpense_1_Q3_USD":6887000.0,"NonoperatingIncomeExpense_3_Q3_USD":2608000.0,"NotesAndLoansReceivableNetNoncurrent_0_Q3_USD":908000.0,"NetIncomeLoss_3_Q3_USD":-78931000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":43000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":500000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":12350000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":8934000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-268926000.0,"Revenues_1_Q3_USD":266000.0,"Revenues_3_Q3_USD":20146000.0,"ShareBasedCompensation_3_Q3_USD":49964000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":14135776.0,"ShortTermBorrowings_0_Q3_USD":38000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":34974000.0,"StockholdersEquity_0_Q3_USD":453186000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":6424000.0,"SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions_3_Q3_USD":9600000.0,"TaxesPayableCurrent_0_Q3_USD":5927000.0,"VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure_0_Q3_USD":3800000.0,"VariableInterestEntityEntityMaximumLossExposureAmount_0_Q3_USD":21100000.0,"VariableInterestEntityInitialConsolidationGainOrLoss_1_Q3_USD":null,"VariableInterestEntityInitialConsolidationGainOrLoss_3_Q3_USD":3543000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":462760000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":13363000.0,"RedeemableNoncontrollingInterestEquityRedemptionValue_0_Q3_USD":0.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q3_USD":0.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":5362000.0,"PaymentsToAcquireOtherInvestments_3_Q3_USD":23659000.0,"PaymentsToAcquireOtherProductiveAssets_3_Q3_USD":273000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":121000.0,"PaymentsToDevelopSoftware_3_Q3_USD":650000.0,"PaymentsToFundLongtermLoansToRelatedParties_3_Q3_USD":2625000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":11551000.0,"PrepaidInsurance_0_Q3_USD":4634000.0,"PrepaidTaxes_0_Q3_USD":2281000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":6067000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":409884000.0,"ProceedsFromIssuanceOfSecuredDebt_3_Q3_USD":2400000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":534000.0,"ProceedsFromNotesPayable_3_Q3_USD":1587000.0,"ProfitLoss_3_Q3_USD":-80971000.0,"ProfitLoss_1_Q3_USD":-31642000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":138000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":6816000.0,"InvestmentIncomeInterest_3_Q3_USD":80000.0,"InvestmentIncomeInterest_1_Q3_USD":8000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":9657000.0,"CommonStockParOrStatedValuePerShare_0_Q3_EUR":0.1,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.12,"CommonStockSharesAuthorized_0_Q3_shares":750000000.0,"CommonStockSharesIssued_0_Q3_shares":159657952.0,"CommonStockSharesOutstanding_0_Q3_shares":159657952.0,"CommonStockValue_0_Q3_USD":17870000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-40328000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-89983000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-2062000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-40800000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-92045000.0,"ContingentConsiderationClassifiedAsEquityFairValueDisclosure_0_Q3_USD":100000.0,"ConvertibleDebt_0_Q3_USD":800000.0,"ConvertibleDebtFairValueDisclosures_0_Q3_USD":9000000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":800000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-472000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":333062000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":430308000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":430308000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":13075000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":3690000.0,"AccruedSalariesCurrent_0_Q3_USD":1388000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-5233000.0,"AdditionalPaidInCapital_0_Q3_USD":709475000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12240000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":192000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":43002672.0,"Assets_0_Q3_USD":484109000.0,"AssetsCurrent_0_Q3_USD":441859000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":469000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-191000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":50000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":1947000.0,"BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_3_Q3_USD":2000.0,"CashAcquiredFromAcquisition_3_Q3_USD":47000.0,"ConvertibleNotesPayable_0_Q3_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":134334685.0,"DebtInstrumentConvertibleConversionPrice1_0_Q3_USD":1654.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q3_USD":-8000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":6462000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":5446000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":8289000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":20264000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":66868000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-26474000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-88022000.0,"FairValueOptionChangesInFairValueGainLoss1_3_Q3_USD":-5530000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-4800000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":368000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":432000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1671000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3266000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":180000.0,"IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent_1_Q3_USD":null,"IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent_3_Q3_USD":null,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-9440000.0,"FairValueOptionChangesInFairValueGainLoss1_1_Q3_USD":-70000.0,"FairValueOfAssetsAcquired_3_Q3_USD":885000.0,"FairValueNetAssetLiability_0_Q3_USD":0.0,"DeferredRevenueCurrent_0_Q3_USD":180000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":18000.0,"DerivativeLiabilities_0_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.59,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.21,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":303000.0,"EquityMethodInvestmentOwnershipPercentage_0_Q3_pure":0.8,"EquityMethodInvestmentQuotedMarketValue_0_Q3_USD":241200000.0,"EquityMethodInvestmentRealizedGainLossOnDisposal_1_Q3_USD":null,"EquityMethodInvestmentRealizedGainLossOnDisposal_3_Q3_USD":16923000.0,"EquityMethodInvestments_0_Q3_USD":15086000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_3_Q3_USD":null,"EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_1_Q3_USD":null,"FairValueAdjustmentOfWarrants_1_Q3_USD":null,"FairValueAdjustmentOfWarrants_3_Q3_USD":41000.0,"FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_1_Q3_USD":47000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q3_USD":336000.0,"DebtInstrumentConvertibleConversionPrice1_0_Q3_EUR":1350.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":151130212.0,"Ticker":"ATAI","CIK":"1840904","name":"ATAI LIFE SCIENCES N.V.","OfficialName":"ATAI Life Sciences N.V. Common Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"834081770.0","Country":"Germany","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]